was more effective at reducing blood-brain barrier permeability (P < 0.05) and improving functional outcome (P < 0.001) compared to the individual compounds. Our results demonstrate that combination therapy with magnesium and an NK1 antagonist may be a more effective therapy for TBI than either compound administered alone.
No takes yet. Share an insight, caveat, or question.
Ameliorate et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: